The human microbiome market will grow at a CAGR of 20.42% to reach US$2.38 billion in 2030 from US$0.94 billion in 2025.
Major factors driving the global human microbiome market growth are increasing instances of lifestyle diseases, diarrheal infections, predominant changes in the lifestyle of the global population, and an increase in the aged population and its applications in healthcare. Moreover, technological enhancements in biomedical sciences and growing research investment in technology and product sectors is also positively impacting the market growth positively. However, lack of awareness about the use and advantages of prebiotics and probiotics and government restrictions on their usage are major challenges for the market players.
The global human microbiome market report provides a detailed analysis of the industry landscape, offering strategic and executive-level insights supported by data-driven forecasts and analysis. This regularly updated report equips decision-makers with actionable intelligence on current market trends, emerging opportunities, and competitive dynamics. It explores consumer demand across various regions and product types, such as therapeutics, diagnostics, and probiotics, while also examining purchasing behaviours and key customer segments. Additionally, the report delves into technological advancements, key government policies, regulation.
| Report Metric | Details |
|---|---|
| Total Market Size in 2025 | USD 0.94 billion |
| Total Market Size in 2030 | USD 2.38 billion |
| Forecast Unit | Billion |
| Growth Rate | 20.42% |
| Study Period | 2020 to 2030 |
| Historical Data | 2020 to 2023 |
| Base Year | 2024 |
| Forecast Period | 2025 – 2030 |
| Segmentation | Product, Disease, Application, Geography |
| Geographical Segmentation | North America, South America, Europe, Middle East and Africa, Asia Pacific |
| Companies |
|